Alexion Pharmaceutical CEO and CFO resign

As the internal accounting probe of the sales numbers of Alexion Pharmaceuticals, Inc. nears completion, its CEO David Hallal and CFO Vikas Sinha have unexpectedly resigned. Mr. Hallal for personal reasons and Mr. Sinha to pursue other opportunities. Wonder what the personal reason and other opportunities are!

What perfect timing! I am most intrigued now what the results of the accounting probe will be.

Weatherford update

Weatherford International announced the sudden exit of it’s CEO Bernard Duroc- Danner. The move though sudden is not unexpected. Recently the company settled with SEC on deceptive accounting charges. The company had overstated its results to meet its earlier announced projections and analyst’s expectation.

In light of that, it would make sense for the company’s CEO to leave, wouldn’t it?